Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $265.64 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $142.04 | 2 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $43.32 | 2 | $0 (2019) |
| Lundbeck LLC | $41.74 | 2 | $0 (2019) |
| Abbott Laboratories | $38.54 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $12.50 | 1 | Abbott Laboratories ($12.50) |
| 2020 | $13.74 | 1 | Abbott Laboratories ($13.74) |
| 2019 | $56.07 | 3 | Sunovion Pharmaceuticals Inc. ($24.40) |
| 2017 | $183.33 | 4 | Otsuka America Pharmaceutical, Inc. ($142.04) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/04/2021 | Abbott Laboratories | Penta SCS Leads (Device) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Neuromodulation | ||||||
| 06/17/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 08/12/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/08/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.37 | General |
| Category: PSYCHIATRY | ||||||
| 02/19/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: CNS | ||||||
| 08/31/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $122.09 | General |
| Category: PSYCHIATRY | ||||||
| 03/01/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: PSYCHIATRY | ||||||
| 02/15/2017 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $22.37 | General |
| Category: PSYCHIATRY | ||||||
| 01/12/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: CNS | ||||||
About Dr. Stephen Griffith, M.D
Dr. Stephen Griffith, M.D is a Psychiatry healthcare provider based in Chowchilla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1548427487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Griffith, M.D has received a total of $265.64 in payments from pharmaceutical and medical device companies, with $12.50 received in 2021. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($265.64).
Practice Information
- Specialty Psychiatry
- Location Chowchilla, CA
- Active Since 05/19/2008
- Last Updated 05/19/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1548427487
Products in Payments
- ABILIFY MAINTENA (Drug) $144.46
- LATUDA (Drug) $43.32
- REXULTI (Drug) $39.32
- Proclaim Family of SCS IPGs (Device) $26.04
- Penta SCS Leads (Device) $12.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.